| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 16.198 | 75.936 | 82.555 | 95.263 | 90.859 | 127.161 | 131.370 | 95.771 |
| Total Income - EUR | - | - | 16.198 | 78.273 | 82.555 | 95.263 | 90.859 | 127.161 | 140.053 | 95.771 |
| Total Expenses - EUR | - | - | 15.763 | 85.706 | 89.784 | 100.511 | 97.339 | 126.984 | 130.008 | 100.273 |
| Gross Profit/Loss - EUR | - | - | 435 | -7.434 | -7.228 | -5.248 | -6.480 | 177 | 10.044 | -4.502 |
| Net Profit/Loss - EUR | - | - | 275 | -8.216 | -8.054 | -5.943 | -7.388 | -1.094 | 8.556 | -4.502 |
| Employees | - | - | 1 | 3 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Corvin Apis Bio Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 5.925 | 4.343 | 9.700 | 6.913 | 4.214 | 1.673 | 0 | 0 |
| Current Assets | - | - | 17.152 | 12.049 | 14.403 | 9.284 | 11.650 | 12.403 | 12.000 | 9.569 |
| Inventories | - | - | 10.723 | 8.451 | 7.760 | 5.382 | 6.697 | 10.524 | 10.011 | 8.949 |
| Receivables | - | - | 4.967 | 2.474 | 2.126 | 2.081 | 2.035 | 0 | 0 | 319 |
| Cash | - | - | 1.462 | 1.124 | 4.517 | 1.821 | 2.918 | 1.879 | 1.989 | 302 |
| Shareholders Funds | - | - | 318 | -7.904 | -15.805 | -21.448 | -28.361 | -29.543 | -20.897 | -25.282 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 22.758 | 24.295 | 39.907 | 37.644 | 44.224 | 43.619 | 32.896 | 34.852 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4719 - 4719" | |||||||||
| CAEN Financial Year |
4719
|
|||||||||
Comments - Corvin Apis Bio Srl